EMC Capital Management’s AbbVie ABBV Stock Holding History

EMC Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$228K	Buy	1,036 +7	+0.7%	+$1.59K	0.1%	60
2025 Q3	$238K	Buy	1,029 +9	+0.9%	+$1.83K	0.11%	70
2025 Q2	$189K	Hold	1,020	–	–	0.1%	84
2025 Q1	$213K	Hold	1,020	–	–	0.13%	141
2024 Q4	$181K	Hold	1,020	–	–	0.1%	171
2024 Q3	$203K	Hold	1,020	–	–	0.13%	158
2024 Q2	$170K	Hold	1,020	–	–	0.1%	183
2024 Q1	$184K	Hold	1,020	–	–	0.11%	183
2023 Q4	$158K	Buy	1,020 +10	+1%	+$1.46K	0.11%	174
2023 Q3	$150K	Buy	+1,010	New	+$148K	0.11%	170

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

EMC Capital Management's ABBV Position: Q4 2025 in Review

EMC Capital Management increased its AbbVie (ABBV) stake by 0.68% in Q4 2025, buying an estimated $1.59K and bringing the position to 1,036 shares worth $228K. The position accounts for 0.1% of the portfolio, ranked #60.

EMC Capital Management first reported a position in ABBV in Q3 2023 and has held it in 10 quarters since. The position peaked at $238K in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

EMC Capital Management held 1,036 shares of AbbVie worth $228K as of Q4 2025.
EMC Capital Management bought 7 AbbVie shares in Q4 2025, an estimated $1.59K.
AbbVie made up 0.1% of EMC Capital Management's portfolio in Q4 2025, its #60 holding.
EMC Capital Management first reported a position in AbbVie in Q3 2023 and has held it in 10 quarters since.
EMC Capital Management's AbbVie position peaked at $238K in Q3 2025.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.